NCT00189722已完成2 期
Inhaled Tacrolimus, Add-on to Inhaled Corticosteroids & Long Acting B2 Agonists in Moderate to Severe Persistent Asthma
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 160
- 试验地点
- 28
研究概览
简要总结
This study will evaluate the efficacy and safety of tacrolimus in patients with asthma.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 70 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Diagnosis of asthma
- •Patients treated with inhaled corticosteroid and long acting beta 2 agonist
- •FEV1(forced expiratory volume in 1 second)>50% to 80%
排除标准
- •Respiratory infection within 2weeks
- •Asthma exacerbation within 6 weeks
研究者
研究点 (28)
Loading locations...
相似试验
已完成
2 期
Dose Response of Inhaled Tacrolimus in Patients With Moderate Persistent AsthmaAsthma, BronchialBronchial AsthmaNCT00189787Astellas Pharma Inc370
已完成
2 期
A Study of the Safety and Efficacy of Tacrolimus Inhalation Aerosol in Subjects With Persistent AsthmaAsthmaNCT00116103Astellas Pharma Inc
招募中
不适用
Tacrolimus Combined With Low-dose Prednisone for Treatment of Myasthenia GravisMyasthenia GravisNCT04768465Da, Yuwei, M.D.160
已完成
不适用
Exacerbation Risk in AsthmaAsthmaNCT05501639Boehringer Ingelheim1,899
已完成
2 期
A Safety and Efficacy Study of Tralokinumab in Adults With AsthmaAsthmaNCT01402986MedImmune LLC689